What is the mid-term cure rate for ovarian tumors

Ovarian tumor is one of the common malignant tumors in women. It can occur in women of any age. The older they are, the greater the incidence. What is the cure rate of ovarian tumor, especially mid-stage ovarian tumor? Let's hear what the experts say.

Experts say that the mid-term cure rate of ovarian tumors varies from person to person. Ovarian tumor treatment is a systematic and complex process. The cure rate is high in the early stage, but in the mid-term, due to the decline in the patient's physical condition, the wide distribution of the tumor, and the wide degree of infiltration, it brings great difficulties to the treatment of ovarian tumors. The key to the mid-term cure rate of ovarian tumors still depends on the formulation of a scientific and reasonable comprehensive treatment plan.

Conventional mid-term treatment methods for ovarian tumors include tumor cell reduction surgery, followed by appropriate radiotherapy and chemotherapy. Here, experts remind that during the mid-term treatment of ovarian tumors, attention should be paid to the short-term or long-term toxic side effects of various auxiliary treatments on patients. Cancer is not the same as other diseases. The mental damage it causes to the body even exceeds the physical damage it causes. As we all know, after surgical resection, the patient's vitality has been severely damaged. After that, radiotherapy and chemotherapy with extremely toxic side effects can easily cause the patient's immunity to decline. For mid-term ovarian tumor patients who cannot tolerate radiotherapy and chemotherapy, it is even worse, accelerating the patient's death, seriously affecting the patient's quality of life, and not beneficial to the patient's survival.

Therefore, the mid-term treatment of ovarian tumors should focus on strengthening the patient's immunity, actively improving the patient's own anti-tumor immunity, and improving the mid-term cure rate of ovarian tumors. Tumor biotherapy is based on the principles of human immunology. Through human intervention, it regulates and enhances the patient's immunity, activates the body's autonomous anti-tumor immune response, inhibits and kills tumor cells, and is of great help in improving the patient's quality of life, prolonging survival, and improving the mid-term cure rate of ovarian tumors.

The above content is the mid-term cure rate of ovarian tumors introduced by experts. I hope you have understood the above content. If you have other questions about the mid-term cure rate of ovarian tumors, please consult online experts, who will give you detailed answers.